Aberrant expression of epidermal growth factor (EGF) receptors and HER2/neu proto-oncogene have been reported in primary lung cancer (Dazzi et al, 1989; Schneider et al, 1989; Kern et al, 1990). Here, ERBB2 is linked to lung cancer.